|
CN102675449A
|
|
Deletion form human keratinocyte growth factor-I disulfide bond mutation form and use thereof
|
|
CN102675452A
|
|
Human insulin/analogue conjugate with continuous blood sugar reduction function and high rate of combination with receptor
|
|
CN102676495A
|
|
Compound mutation of immunosuppressive agent microbial strains
|
|
CN102633874A
|
|
Chemical coupling matter of deletion-recombination human keratinocyte growth factor I type
|
|
CN102462660A
|
|
Preparation and application of oil-in-water emulsion of borneol
|
|
CN102465129A
|
|
Solubility expression and preparation of human fibroblast growth factor 21 in procaryotic cell
|
|
CN102462662A
|
|
Liposome-encapsulated recombinant human ciliary neurotrophic factor
|
|
CN102465146A
|
|
Recombinant preparation of T4 endonuclease V through fusion expression
|
|
CN102464712A
|
|
Deletion human fibroblast growth factor 21 variant and conjugate thereof
|
|
CN101993485A
|
|
Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof
|
|
CN101993496A
|
|
Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof
|
|
CN101993489A
|
|
Reversible hirudin
|
|
CN101993494A
|
|
N-terminal chemical modification and application of human fibroblast growth factor-21 (hFGF-21)
|
|
CN101885776A
|
|
N-end chemical modification of ciliary neurotrophic factor (CNTF) and preparation method thereof
|
|
CN101717449A
|
|
Recombinant TRAIL-Fc fusion protein as well as preparation and application thereof
|
|
CN1663960A
|
|
High-efficiency expression recombinant human proinsulin and its analogue C peptide
|
